Legal Opinion
Endo Pharmaceuticals Solutions v. Custopharm Inc.
Court of Appeals for the Federal Circuit
Decided July 13, 2018No. 2017-1719PublishedCited by 4 opinions
1Opinion of the Court
Chen, Circuit Judge.
Endo Pharmaceuticals Solutions, Inc. (Endo) holds the approved New Drug Application for Aveed ® , a testosterone undecanoate (TU) intramuscular injection. Bayer Intellectual Property GmbH and Bayer Pharma AG (Bayer) own the two patents listed in the Orange Book for Aveed ® , U.S. Patent Nos. 7,718,640 (the '640 patent) and 8,338,395 (the '395 patent). Custopharm Inc.'s (Custopharm) predecessor-in-interest, Paddock Laboratories, LLC, submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) for approval to produce and market a…
2Cases cited16 opinions
- KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
- Continental Can Company Usa, Inc. And Continental Pet Technologies, Inc. v. Monsanto Company, Hoover Universal, Inc. And Johnson Controls, Inc.Court of Appeals for the Federal Circuit · 1991
- Pfizer, Inc. v. Apotex, Inc.Court of Appeals for the Federal Circuit · 2007
- In Re Denis Rouffet, Yannick Tanguy and Frederic BerthaultCourt of Appeals for the Federal Circuit · 1998
- Par Pharmaceutical, Inc. v. Twi Pharmaceuticals, Inc.Court of Appeals for the Federal Circuit · 2014
11 more not listed; retrieve them via the Exa API.
3Cited by4 opinions
- Persion Pharmaceuticals LLC v. Alvogen Malta Operations Ltd.Court of Appeals for the Federal Circuit · 2019
- Hospira, Inc. v. Fresenius Kabi USA, LLCDistrict Court, E.D. Illinois · 2018
- Hyatt v. StewartCourt of Appeals for the Federal Circuit · 2025
- Purdue Pharma L.P. v. Accord Healthcare Inc.District Court, D. Delaware · 2023